? Cancer Prevention and Control Program The UNC Lineberger Cancer Prevention and Control Program focuses on the development, evaluation, and dissemination of evidence-based interventions and policy approaches to improve cancer outcomes in North Carolina and beyond. Our program is comprised of leading scientists and clinicians with backgrounds in psychology, sociology, health behavior, health services research, nutrition, exercise physiology, statistics, nursing and oncology all focused on improving understanding of the prevention and control of cancer. There are four broad themes in the program: (1) implementing health promotion interventions to reduce cancer risk factors and eliminate cancer health disparities; (2) developing cancer communication strategies to improve cancer outcomes; (3) improving quality of cancer care and long-term outcomes for cancer survivors; and (4) studying patterns of cancer care, screening, and prevention to inform interventions and policy initiatives that improve cancer outcomes. The program has received substantial new investment in infrastructure, research support and recruitment as befits one of three major UNC Lineberger strategic directions, ?Optimizing Cancer Outcomes in North Carolina?. Highlights of nationally recognized research by program investigators include tobacco control policy research that guides state and national policy on the sales and marketing of electronic cigarettes, and design of graphic cigarette warning labels; research on Internet and mobile interventions for diet/obesity/physical activity in adolescents and adults with a particular focus on disadvantaged populations and cancer survivors; understanding the impact of message tailoring and other health communication strategies; development of national cancer survivorship care plans; creation of unique multi-payer linked databases for cancer outcomes research; and novel patient-reported outcomes studies that inform national policy. The Program is led by Dr. Kurt Ribisl, a behavioral scientist and Dr. Ethan Basch, a medical oncologist and health services researcher. Program members are PIs of three NCI funded pre- and post-doctoral training grants. The Program adds value in terms of integrative activities and opportunities for collaboration, access to shared resources, such as the Communications for Health Applications and Interventions, Biostatistics, and Outcomes Cores, as well as space, seminars, retreats, and training and education. UNC Lineberger has benefited the Program through strong support for faculty recruitments, extensive use of shared resources, and providing developmental funds. Significant faculty recruiting supported by the Center has resulted in 22 new program members including nationally-recognized senior investigators and promising junior faculty. There are 45 program members and our program has strong collaborations between faculty from the Schools of Medicine, Public Health, Nursing, and Journalism and the College of Arts and Sciences. During the last funding period, program members have published 951 cancer-related articles (34% collaborative). In 2014, our program members held 93 grants and $31M (total cost) in annual extramural funding, including 38 grants and $13.6M (total costs) from the NCI. Program members accrued 1984 subjects to research studies.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA016086-44
Application #
9834879
Study Section
Subcommittee I - Transistion to Independence (NCI)
Project Start
Project End
Budget Start
2019-12-01
Budget End
2020-11-30
Support Year
44
Fiscal Year
2020
Total Cost
Indirect Cost
Name
University of North Carolina Chapel Hill
Department
Type
DUNS #
608195277
City
Chapel Hill
State
NC
Country
United States
Zip Code
27599
Hosseinipour, Mina C; Kang, Minhee; Krown, Susan E et al. (2018) As-Needed Vs Immediate Etoposide Chemotherapy in Combination With Antiretroviral Therapy for Mild-to-Moderate AIDS-Associated Kaposi Sarcoma in Resource-Limited Settings: A5264/AMC-067 Randomized Clinical Trial. Clin Infect Dis 67:251-260
Ren, Jianke; Hathaway, Nathaniel A; Crabtree, Gerald R et al. (2018) Tethering of Lsh at the Oct4 locus promotes gene repression associated with epigenetic changes. Epigenetics 13:173-181
Huang, Weigang; Wang, Xiaoyang; Endo-Streeter, Stuart et al. (2018) A membrane-associated, fluorogenic reporter for mammalian phospholipase C isozymes. J Biol Chem 293:1728-1735
Smitherman, Andrew B; Anderson, Chelsea; Lund, Jennifer L et al. (2018) Frailty and Comorbidities Among Survivors of Adolescent and Young Adult Cancer: A Cross-Sectional Examination of a Hospital-Based Survivorship Cohort. J Adolesc Young Adult Oncol 7:374-383
Zheng, Xiaojing; O'Connell, Catherine M; Zhong, Wujuan et al. (2018) Discovery of Blood Transcriptional Endotypes in Women with Pelvic Inflammatory Disease. J Immunol 200:2941-2956
Jenkins, Mark A; Win, Aung Ko; Templeton, Allyson S et al. (2018) Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC). Int J Epidemiol 47:387-388i
Williams, Rebecca S; Derrick, Jason; Liebman, Aliza K et al. (2018) Content analysis of e-cigarette products, promotions, prices and claims on Internet tobacco vendor websites, 2013-2014. Tob Control 27:e34-e40
McRee, Autumn J; Marcom, Paul K; Moore, Dominic T et al. (2018) A Phase I Trial of the PI3K Inhibitor Buparlisib Combined With Capecitabine in Patients With Metastatic Breast Cancer. Clin Breast Cancer 18:289-297
Efird, William M; Fletcher, Alex G; Draeger, Reid W et al. (2018) Deferoxamine-Soaked Suture Improves Angiogenesis and Repair Potential After Acute Injury of the Chicken Achilles Tendon. Orthop J Sports Med 6:2325967118802792
Patel, Nirali M; Michelini, Vanessa V; Snell, Jeff M et al. (2018) Enhancing Next-Generation Sequencing-Guided Cancer Care Through Cognitive Computing. Oncologist 23:179-185

Showing the most recent 10 out of 1525 publications